John Kanzius - see video below

[Best Syndication] A Florida man has been said to have invented a machine that could cure cancer. Reports from WPBF, a West Palm Beach NBC TV station reported on this after the American Cancer Society website reported on the potentially new alternative to chemotherapy treatment.

The researcher is not a medically trained individual and was a former broadcast exective from Pennsylvania. John Kanzius is 63 years old and thought he could use his knowledge of physics and radio to treat cancer, which he also is suffering from. Kanzius worked on his invention in his garage in Sanibel Island, Florida.

Kanzius described how his invention works by using gold or carbon nanoparticles that are injected into the subject. The nanoparticles which are only one-billionth of a meter would attach to the cancer cells. Once the particles are attached to the cancer cells they would enter a machine that would give off radio frequency waves that is supposed to heat and kill the cancer cells but not damaging healthy cells.

Colon polyp on a short stalk

(Best Syndication) People with coronary artery disease were much more likely to suffer from colorectal tumors and lesions, according to research done in Hong Kong. The study published in the September 26 issue of the Journal of the American Medical Association (JAMA) indicates that people who were diagnosed with heart disease were twice as likely to have colon cancer and tumors.

They found that people with coronary heart disease, as determined by CAD scan, were more likely to have tumors or precancerous lesions. “Colorectal neoplasms and advanced lesions were more prevalent (34.0 percent and 18.4 percent, respectively) in the CAD-positive group than in the CAD-negative (18.8 percent and 8.7 percent) and general population (20.8 percent and 5.8 percent) groups,” the authors wrote.

stock photo

[Best Syndication] Dr. Oz visited on the Oprah TV show and discussed the benefits of eating a high fiber diet. Dr. Oz shared different studies from a new show that he is hosting on the Discovery Channel called, ‘The Truth about Food.’ It is a six part series that looks at how food affects our health.

The surprise that Dr. Oz did today on ‘Oprah’ was to swallow a pill-cam which is a camera that travels through the digestive track and takes pictures all the way down. Dr. Oz showed pictures of his digestive track to the viewers and the audience throughout the show. In order to see the digestive tract walls he did not eat anything for 24 hours. This pillcam Dr. Oz explained has been used by over a half of million people to help diagnose medical problems.

Stock Photo

(Best Syndication) Researchers in Ohio say that the same chemical that gives fruits and vegetables their bright colors can hold the key to preventing cancer. The compounds, called anthocyanins, give the fruits and vegetables that “most red, purple and blue” colors and will also “appreciably slow the growth of colon cancer cells”.

Anthocyanins (from Greek: anthos or flower and kyanos or blue) is a water-soluble vacuolar flavonoid pigment that can appear red to blue, depending on pH. They are found in all tissue of the higher plants and provide the colors to the roots, flowers, stems and fruits. The very same chemicals are used by the plant to attract pollinators, provide protection from the sun and even camouflage. Possibly their most important role is as an antioxidant, protecting the plant from radicals formed by UV sunlight during the metabolic process.

stock photo

[Best Syndication] Colon cancer patients that ate a diet high in meat, refined carbohydrates, fat, and desserts showed an increased risk of cancer coming back and also had higher rates of death compared to those that ate a diet full of fruits, vegetables, poultry, and fish. The study first was published in the August 15th issue of JAMA.

Lifestyle factors have been previous studied on the risk for developing colon cancer. This study focused on recurrence and survival rates due to dietary habits.

Jeffrey A. Meyerhardt, M.D., M.P.H., of the Dana-Farber Cancer Institute, Boston, and colleagues studied 1,009 stage III colon cancer patients that were enrolled in a clinical trial of postoperative chemotherapy along with other treatments.